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Abstract: High-intensity exercise damages mitochondrial DNA (mtDNA) in skeletal muscle. 
Whether MitoQ - a redox active mitochondrial targeted quinone - can reduce exercise-induced 
mtDNA damage is unknown. In a double blind, randomized, placebo-controlled design, 
twenty-four healthy male participants consisting of two groups (placebo; n=12, MitoQ; n=12) 
performed an exercise trial of 4 x 4-minute bouts at 90-95% of heart rate max. Participants 
completed an acute (20mg MitoQ or placebo 1-hour pre-exercise) and chronic (21 days of 
supplementation) phase. Blood and skeletal muscle were sampled immediately pre- and post-
exercise and analysed for nuclear and mtDNA damage, lipid hydroperoxides, lipid soluble 
antioxidants, and the ascorbyl free radical. Exercise significantly increased nuclear and 
mtDNA damage across lymphocytes and muscle (P < 0.05), which was accompanied with 
changes in lipid hydroperoxides, ascorbyl free radical, and α-tocopherol (P < 0.05). Acute 
MitoQ treatment failed to impact any biomarker likely due to insufficient initial bioavailability. 
However, chronic MitoQ treatment attenuated nuclear (P < 0.05) and mtDNA damage in 
lymphocytes and muscle tissue (P < 0.05). Our work is the first to show a protective effect of 
chronic MitoQ supplementation on the mitochondrial and nuclear genomes in lymphocytes 
and human muscle tissue following exercise, which is important for genome stability. 
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Highlights: 
• Exercise damages mitochondrial DNA in lymphocytes and muscle tissue. 
• Acute MitoQ ingestion has no impact on biomarkers of oxidative stress. 
















Mitochondria have an established role in the life cycle of a cell, contributing to cellular networks 
aligned to metabolism, biosynthetic pathways, and apoptotic cell death [1]. Although the 
relationship between mitochondrial dysfunction and disease is complex, and the associated 
underlying mechanisms are still being investigated [2], a common denominator across a 
multitude of pathologies is an increased generation of reactive species, and subsequent 
mtDNA damage [3]. Mitochondrial DNA damage impairs bioenergetics, apoptosis, cell 
proliferation, and in turn, increases the likelihood of compromised organ function and 
pathology [4,5]. 
Exercise increases the univalent reduction of ground state molecular dioxygen (O2) to 
superoxide (O2·-) in skeletal muscle. NADPH oxidase enzymes are thought to dominate 
exercise-induced O2·- production, in part, because several factors (notably ATP demand) 
should decrease mitochondrial O2·- production. Intriguingly, while net mitochondrial O2·- 
production is decreased, the flavin mononucleotide of complex I continues to produce O2·- in 
a metabolic milieu mimicking exercise in isolated mitochondria [6]. This observation combined 
with the potential for significant mitochondrial O2·- production in the minutes and hours after 
acute exercise, and their ability to act as a hydrogen peroxide (H2O2) sink helps to reconcile 
our previous finding that exercise increases mtDNA damage (specifically 8-hydroxy-2-
deoxyguanosine) [7]. Mechanistically, H2O2 potentiates proximal hydroxyl radical production 
by reacting with transition metals (e.g., Cu+) bound to DNA; thus, initiating the downstream 
generation of various oxidation products including, 8-hydroxy-2-deoxyguanosine. Presence of 
this commonly quantified base adduct following exercise is indicative of hydroxyl radical 
addition to guanine’s eighth position as guanine is the most readily oxidised base [8]. To date, 
the literature surrounding exercise-induced DNA damage has focused on nuclear DNA 
damage [9]; however, the lack of complex chromatin organisation and histone proteins [10,11], 
the accumulation of vicinal transition metal ions (e.g., ferrous iron), and the potential activation 
of secondary DNA- and lipid-oxidation products collectively make mtDNA more susceptible to 
oxidative attack compared to nuclear DNA [12,13]. Understanding and manipulating exercise-
induced mtDNA damage is important for avoiding mtDNA heteroplasmy and maintaining 
genome integrity [14]. Interest in curtailing mtDNA damage has led to the development of 
several mitochondria targeted antioxidants including: MitoE [15], tiron [16–18], and MitoC [19]. 
One such therapeutic compound is the orally-available mitochondrial-targeted 
coenzyme Q10, termed Mitoquinone (MitoQ) [20]. Accumulation of coenzyme Q10 within 
mitochondria is limited by high lipophilicity, large molecular weight, and poor aqueous 
solubility, and as a result clinical trials often administer high doses [21]. Conversely, a 
triphenylphosphonium cation enables MitoQ to accumulate in mitochondria at approximately 
100-1000 times greater than non-targeted derivatives [22]. Lipophilic cations increase their 
accumulation 10-fold for every 61.5 mV of membrane potential in accordance with the Nernst 
equation; this effective uptake is also supported by the plasma membrane potential [23]. Once 
absorbed, MitoQ is primarily reduced by complex II (but also glyceraldehyde 3-dehydrogenase 
in some tissues) to ubiquinol [24,25], which can act as a chain breaking antioxidant, and 
regenerate the alpha-tocopherol radical (ROO· + α-TOH → ROOH + α-TOH· [k = 105 - 106 M-
1s-1]; α-TOH· + RH (PUFA) → α-TOH + R· (Alkyl Radical) [k = 1 × 10-1 M-1s-1]). Accordingly, 
MitoQ attenuates lipid peroxidation in isolated mitochondria [24,26] and peroxynitrite mediated 
oxidative damage [25]. Other protective effects of MitoQ have been observed in clinical 
applications including cardiac ischemia/reperfusion injury [27], chronic nitroglycerin exposure 
[28,29], sepsis (Supinski et al., 2009) and liver damage [31], solidifying MitoQ as an attractive 
compound with potential therapeutic treatment for certain human diseases.  
The majority (if not all) of exercise studies have used pleiotropic, non-selective 
antioxidants with unknown tissue distribution and quantification in an attempt to infer 
mechanistic conclusions relating to redox signalling from oxidative stress biomarkers [32]. 
Exercise-based research is clearly warranted to unambiguously clarify a regulatory 
mechanism between redox molecular modifications and a physiological outcome after 
administration of a targeted antioxidant [33]. Recently, Pham and colleagues (2020) 
demonstrated the ability of chronic MitoQ supplementation (20 mg/day) to suppress 
mitochondrial H2O2 release ex vivo and increase the expression of several enzymatic 
antioxidants. While their work adds to current understanding, whether MitoQ can impact a 
functionally and translationally important sentinels of mtDNA damage is unknown. 
Accordingly, we aimed to determine whether: (1) a bout of high-intensity intermittent exercise 
(HIIE) damaged mtDNA; and (2) MitoQ could prevent mtDNA damage.  
 
2. Materials and Methods 
2.1. Participants 
Twenty-four (n = 24) apparently healthy, recreationally active males (age 25 ± 4 years, stature 
181 ± 4 cm, mass 87 ± 11 kg) volunteered and subsequently provided their medical history 
prior to written informed consent. All participants were non-smokers and free from any form of 
medication or antioxidant supplementation for 4-weeks prior to, and throughout the study. The 
study was conducted in accordance with the Declaration of Helsinki and approved by a local 
University Ethics Committee. 
 
2.2. Acute and Chronic Supplemention 
In a double-blind, randomized, placebo-controlled design, participants were allocated to two 
groups: MitoQ (n = 12) and placebo (n = 12), and subsequenly took part in a two-phased 
supplementation trial. For the acute phase, either 20 mg MitoQ (Antipodean Pharmaceuticals; 
CA, USA), or placebo (Antipodean Pharmaceuticals [microcrystalline cellulose, tapioca, silicon 
dioxide]) excluding the active ingredient was consumed 1-hour pre- exercise. MitoQ dosing 
was informed by previous human research [35,36]. Following HIIE, participants continued to 
supplement in their respective groups for 21-days (chronic phase). A schematic overview of 
the experimental trial is depicted in Figure 1. Participants were instructed to consume MitoQ 
in a fasted state to maximise absorption based on known pharmacokinetic data (personal 
communication Prof. Michael Murphy, University of Cambridge). 
 
*INSERT FIGURE 1* 
 
2.3. High-Intensity Intermittent Exercise 
For all experimental testing, participants were required to complete a standardised 12-hour 
overnight fast, and to refrain from exercise and alcohol for 48-hours prior to testing. Following 
the familiarisation phase, participants completed an incremental test to exhaustion to 
determine maximum heart rate (HRmax). Participants cycled at a cadence of 70-90 revolutions 
per minute on a friction-braked cycle ergometer (Monark, Sweden) to produce a power output 
equivalent to their bodyweight (1W/kg). Workload was increased by 0.5W/kg of body weight 
every 2 minutes until the participant could no longer maintain the required work rate [37].  
Following the incremental exercise test to exhaustion, participants completed HIIE 
consisting of 4 x 4-minute bouts. Each 4-minute work interval corresponded to 90-95% of 
HRmax with a 3-minute active recovery at 70% of HRmax [38].  Continuous heart rate (HR) 
monitoring was achieved via a portable short-angle telemetry device (Polar, Finland). 
Participants could drink water ad libitum. 
 
2.4. Haematology and Muscle Tissue Sampling  
Blood was sampled from a prominent antecubital forearm vein pre-supplementation, post 
acute supplementation (pre-exercise) and immediately post-exercise for both the acute and 
chronic phases. Peripheral blood mononuclear cells (PBMCs) were isolated by layering 3 ml 
of whole blood onto 3 ml of Histopaque-1077 (Signma-Aldrich, St. Louis, MO), and centrifuged 
at 3500 rpm for 30 minutes at 4°C. All blood was extracted using the vacutainer method, and 
subsequently centrifuged, aliquoted, and stored at -80°C prior to biochemical analysis. An 
exercise-induced haemoconcentration was determined using the equations of Dill and Costill 
(1974), incorporating haemoglobin and haematocrit indices. Packed cell volume (%) was 
measured using the microcapillary reader technique and corrected by 1.5% for plasma trapped 
within erythrocytes [40]. 
A randomised subsample of participants provided skeletal muscle tissue (MitoQ, n = 
5; Placebo, n = 5), extracted at baseline, and pre- and post-exercise time points in chronic 
phase. Briefly, following local anesthesic (2% lidocaine), a small incision was made using a 
single-use sterile scalpel (Swan-Morton, Sheffield, England). The biopsy device (Acecut 
biopsy needle, TSK laboratories, Soja, Japan) was subsequently inserted at a 90-degree 
angle to the skin edge, and triggered to capture the muscle sample. The same investigator 
extracted all muscle tissue samples. Once collected, samples were immediately flash frozen 
in liquid nitrogen and stored at -80°C until subsequent analysis.  
 
2.6. Global Mitochondrial DNA Damage  
A Long Amplicon-Quantitative Polymerase Chain Reaction (LAq-PCR) assay was utilised to 
determine total mtDNA damage. Total DNA was extracted from lymphocytes, human muscle 
tissue, and mouse C2C12 myoblasts using a Qiagen Genomic-Tip kit as previously outlined 
by Hunter et al. (2010) and Furda et al. (2012) DNA quality and purity were quantified using a 
Nanodrop 2000 (Thermo Scientific, USA) spectrometry method (A260/A280 ≥ 1.85). 
DNA was quantified using PicoGreen as per manufacturers instructions, and 
flouresence was measured with a 485 nm excitation filter and a 530 nm emission filter. 
Lambda DNA/HindIII was used to construct a standard curve to determine the concentration 
of unknown samples. All DNA samples were stored in TE buffer (10 mM Tris/1 mM EDTA) at 
4°C.  
50 µl reactions were prepared by combining the following: KAPA Long Range HotStart 
PCR Kit (Sigma-Aldrich, UK: Nuclease-free H2O for a final volume of 50 μl, 5 μl 3 ng/μl sample 
DNA [total 15 ng template], 10 μl 5× buffer solution, 1 μl 1.0 mg/ml BSA, 1 μl 10 mM dNTP 
mix, 2.5 μl each 10 μM primer, 3.5 μl 25 mMgCl2, 0.5 μl 2.5 U/μl KAPA HotStart polymerase). 
Note: Primer nucleotide sequences and corresponding conditions are outlined in Table 1. 
These 50 μl mixes included both a no template control, and a 50% control, containing control 
DNA. These control samples ensured a lack of contamination in the reaction component and 
to ensure quantitative conditions within the linear range of fragment amplification, respectively. 
 
*INSERT TABLE 1* 
 
Each sample was vortexed briefly and subsequently centrifuged for approximately 10 seconds 
before being aliquoted into the well of a PCR plate at a volume of 25 μl. PCR products were 
amplified based on the conditions presented in Table 2. 
 
*INSERT TABLE 2* 
 
To quantify products, 90 μl of TE buffer was added to 10 μl of PCR product and 
performed in triplicated within a 96-well PCR plate. Fluorescence was quantified via 
PicoGreen incubated in the dark for 10-minutes, and measured with at an excitation of 485 
nm and emission of 530 nm. Each of the triplicate sample values were averaged and 
subtracted from the no template control and fluorescence from the fluorescence values for the 
PCR products, including the 50% control. 
Large mitochondrial PCR products were subsequently normalised for copy number 
using fluorescence values of small mitochondrial PCR products as recommended by Furda et 
al. (2012). Before normalising samples, a correction factor was quantified by dividing each of 
the small mitochondrial PCR products by the mean of all the small mitochondrial products. 
Subsequently, the normalised fluorescence values were divided into each sample by the 
average normalised fluorescence value to give the amplification relative to the control. Finally, 
a negative natural log (-ln) was performed on each amplification figure to quantify the lesion 
frequency per fragment. This was normalised to the number of lesions/10kb to quantify the 
extent of mtDNA damage. 
 
2.7. DNA Single Strand Breaks  
DNA damage was measured in PBMCs using the single cell gel electrophoresis termed the 
comet assay [43]. Briefly, 50 µl of isolated lymphocytes were mixed with 150 µl of low melting 
point agarose, of which 70 µl was layered on to normal agarose slides and allowed to solidify 
under coverslips at 4°C. After 5 minutes, the coverslips were removed and placed in lysis 
buffer (2.5M NaCl, 100mM NaEDTA, 10mM Trizma, 1% Trition-X, pH 10) for 1 hour at 4°C. 
Slides were then placed in electrophoresis solution (300 mM NaOH, 1 mM EDTA, pH 12.5-
13) for a 20-minute incubation period, followed by 30 minutes electrophoresis at 4°C 
(0.83V/cm). Slides then underwent neutralisation followed by staining using SYBR® Gold. 50 
random cells were counted on each slide using an Olympus BH-2 epifluorescence 
microscope. Slides were prepared and counted in duplicate with the mean DNA damage 
recorded. All steps were carried out in the dark to prevent further DNA damage. A H2O2 
(Sigma-Aldrich, U.K.) series was performed by incubating lymphocytes for 20 minutes at 
different dilutions, to act as a positive control for the standard alkaline comet assay. The 
intra/inter-assay co-efficient of variation (CV) are <8%.  
 
2.5. C2C12 Cell Culture 
Mus Muculus C2C12 myoblasts (American Type Culture Collection, CRL-1772) were 
incorporated to provide an insight to the mechanisms of oxidative damage to DNA by acting 
as a positive control. Cell cultures were grown as previously described by Kislinger et al. 
(2005) in Dulbecco’s Modified Eagle’s Medium (Invitrogen) supplemented with 20% fetal 
bovine serum, 200 mM L-glutamine, 10 units/ml penicillin, and 10 µg/ml streptomycin at 37°C 
in a humified atmosphere of 5% CO2. Adherent cells were harvested by trypsin incubation 
using 0.05% trypsin in EDTA (Gibco, USA) and seeded at a density of 1 x 105. Cell viability 
was assessed using the trypan blue exclusion assay (Sigma-Aldrich), with all experimental 
cells exceeding ≥95% viability [45]. All samples were incubated with exogenously applied H2O2 
of an incrementally increasing concentration for 30-minutes. This was performed at 4°C to 
attenuate DNA repair.  
 
2.8. Lipid Hydroperoxides (LOOH) 
Serum LOOH were measured spectrophotometrically using the method of Wolff (1994). 
Briefly, ferrous oxidation of Xylenol Orange (FOX) was used to quantify the oxidation of ferrous 
(Fe2+) iron to ferric (Fe3+) iron ions, and the subsequent binding of Fe3+ to the FOX-1 reagent. 
The intra/inter-assay coefficient of variation (CV) is <5%. 
 
2.9. Lipid Soluble Antioxidants (LSA) 
LSA were analysed by simultaneous determination using high-performance liquid 
chromatography (HPLC) as described by Thurnham et al. (1988). Serum samples were 
measured under the same testing parameters outlined in McClean et al. (2015) for α-
tocopherol, γ-tocopherol, retinol, xanthophyll, and β-carotene at changing wavelengths. The 
intra/inter-assay coefficient of variation (CV) is <7%. 
 
2.10. Electron Paramagnetic Resonance (EPR) Spectroscopy 
The ascorbyl free radical was quantified using EPR on a Bruker EMX EPR spectrometer 
(Bruker Instruments Inc., Billerica, MA, USA) as described by Williamson et al. (2020). 1 mL 
plasma was mixed thoroughly with 1 mL dimethyl sulfoxide in a glass test tube, and 1 mL of 
the final solution was drawn into a sterile syringe and flushed into the analyser cavity. The 
spectrometer parameter conditions were set as follows: frequency (9.785 GHz); microwave 
power (20 mW); modulation frequency (100 kHz) and modulation amplitude (1.194 G) for three 
sweeps.  Spectral parameters were obtained using commercially available software (Bruker 
Win EPR System, Version 3.2) and filtered identically. The relative concentration of the 
ascorbyl radical was determined by signal intensity. All samples were analysed at room 
temperature. 
 2.11. Statistical Analysis 
SPSS statistical software (IBM, Surrey, UK, v.25) was used to analyse data sets, and data 
normality was determined using the Shapiro-Wilks test (P > 0.05). Data was analysed using a 
two-way ANOVA with alpha P < 0.05. Following a significant interaction effect, between group 
differences were analysed using a one-way ANOVA, while a Bonferroni paired samples t-test 
was used for within time differences. All data are represented as mean (M) ± standard 
deviation (SD), with the expection of mtDNA damage, where error bars represent mean ± 
standard error of the mean as recommended by Hunter et al., (2010) and Furda et al. (2012). 




Assessment of adherence was ascertained through two indirect measures to improve 
accuracy of reporting: pill/bottle counts and questioning the participant during laboratory visits 
[50]. All 24 participants (100%) completed both the acute and chronic phases of the study. 
From a total of 528 administration opportunities (across all participants, and all phases), only 
2 tablets were missed, thus compliance was 99.6% for the entire study. No adverse side 
effects as a result of MitoQ consumption were reported during the supplementation period. 
 
 
3.2. Heart Rate  
Heart rate across exercise trials, and following acute and chronic supplementation, were 
similar (P > 0.05) as shown in Figure 2.  
 
*INSERT FIGURE 2* 
 
3.3. Lymphocyte Nuclear DNA Damage 
 
Acute-Supplementation  
Exercise-induced DNA damage following acute MitoQ supplementation is depicted in Figure 
3A. There was an interaction effect for time × group (P < 0.05, ES = 0.4), and post-hoc analysis 
shows a difference between pre- and post-exercise time points for each intervention group (P 
< 0.05, ES = 0.7, [Placebo = Δ34.1%; MitoQ = Δ27.1%] ). Additionally, there was a main effect 
for time (pooled group pre- vs. post-exercise, P < 0.05, ES = 0.7). No interaction effect 
between groups was observed (P > 0.05). 
 
Chronic Supplementation  
Following chronic MitoQ supplementation (Figure 3B), there was a time x group interaction 
effect (P < 0.05, ES = 0.5), with post-hoc analysis demonstrating a difference between placebo 
and MitoQ groups post-exercise (P < 0.05, ES = 0.2). Furthermore, there was a within (pre- to 
post-exercise) group effect (P < 0.05, ES = 0.4, [Placebo = Δ28.9%; MitoQ = Δ15.9%] ).  
 
*INSERT FIGURE 3* 
 
3.4. Lymphocyte Mitochondrial DNA Damage  
 
Acute-Supplementation  
An increase in mtDNA damage (P < 0.05, ES = 0.53, see Figure 4A) was observed following 
HIIE. There was no difference in mtDNA damage between baseline and pre-exercise time 
points after supplementation (P > 0.05). No between group differences were observed 
between pre- and post-exercise time points (P > 0.05), suggesting acute supplementation of 
MitoQ failed to protect against exercise induced mtDNA damage. 
 
Chronic Supplementation  
There was an increase in mtDNA damage following exercise (pooled data; P < 0.05, ES = 
0.53, see Figure 4B).  An interaction effect of time and group was also observed (P < 0.05, 
ES = 0.29), consistent with MitoQ protecting against exercise-induced mtDNA damage.   
 
*INSERT FIGURE 4* 
 
3.5. Human Muscle Mitochondrial DNA Damage 
 
Chronic Supplementation  
There was a time x group interaction effect at post-exercise (P < 0.05, ES = 0.38, see Figure 
5), indicating that chronic MitoQ supplementation protects against mtDNA damage in muscle.  
 
*INSERT FIGURE 5* 
 
3.6. Mouse C2C12 Mitochondrial DNA Damage 
Mitochondrial DNA damage in C2C12 myoblast cells demonstrated a dose-dependent 
increase following exposure to H2O2 (Figure 6). The observed damage at 50-100 µM is similar 
to that observed in our human lymphocyte and muscle cells. 
 
*INSERT FIGURE 6* 
 
3.7. Lipid Hydroperoxides 
 
Acute Supplementation  
There was no time x group interaction effect for LOOH’s following acute MitoQ treatment (P > 
0.05, ES = 0.14, Figure 7A). However, lipid hydroperoxides increased in placebo (Δ34%, P < 




Chronic Supplementation  
There was no between group effect (P > 0.05, ES = 0.21) as observed in Figure 7B. However, 
a within group effect in both the placebo (Δ27%, P = 0.03) and MitoQ (Δ12%, P = 0.01) groups 
was observed.   
*INSERT FIGURE 7* 
 
3.8. Ascorbyl Free Radical 
There was no time x group interaction effect in ascorbyl free radical concentration (P > 0.05) 
following acute or chronic supplementation (Table 3). However, further analysis of pooled data 
(pre- vs. post-exercise) shows a main effect of time in both acute (P = 0.02) and chronic (P = 
0.03) experimental trials.  
 *INSERT TABLE 3* 
 
3.9. Lipid Soluble Antioxidants 
There was no interaction effect across any LSA parameter (P > 0.05, see table 4), however, 
there was a main effect for time in α-tocopherol for both acute (pooled data; P < 0.05, ES = 
0.1) and chronic (pooled data; P < 0.05, ES = 0.2) experimental phases. 
 




To date, knowledge of how exercise impacts mtDNA damage is lacking [7,9]. Recently, it has 
been proposed that the simultaneous, beneficial (e.g., signal) and harming (e.g., damage to 
macromolecules) effects of exercise induce a state of oxidative eustress, which is largely 
dependent on the local microenvironment (pH, temperature, solvent accessibility, and vicinal 
interactome) [51]. Building on the limited body of literature, we offer novel insights into the role 
of exercise-induced redox perturbations in mitochondria. We demonstrate an increase in DNA 
damage (mitochondrial and nuclear) and lipid peroxidation, in tandem with the detection of the 
ascorbyl free radical suggesting that HIIE increases the generation of reactive species [52]. 
Similarly, the presence of the ascorbyl free radical suggests that ascorbic acid is oxidised to 
potentially scavenge other free radicals including, O2·-, hydroxyl, and lipid-derived alkoxyl and 
peroxyl radicals [53,54]. Together the increase in oxidative damage within PBMC (nuclear and 
mtDNA), muscle tissue (mtDNA), and corresponding changes to lipid hydroperoxides, lipid 
soluble antioxidants, and the presence of the ascorbyl free radical signifies perturbed redox 
homeostasis. 
One major finding is that exercise increased DNA damage in nucleus and mitochondria. 
While several factors (e.g., lack of histones) render mtDNA more susceptible to damage than 
nuclear DNA, the chemistry underlying the observed damage is similar (reviewed in [55]). In 
brief, local H2O2 reacts with accessible transition metals to produce the damaging hydroxyl 
radical species via Fenton-type chemistry (H2O2 + Fe2+ → Fe3+ + −OH + ·OH [k ~ 76 M−1 s−1]; 
H2O2 + Cu+ → Cu2+ + −OH + ·OH [k ~ 4.7 × 103 M−1 s−1]) [55,56]. Note, the rate for Fe2+ 
increases by 2-3 orders of magnitude when it is bound to citrate or ATP. Hydroxyl radical 
reacts with DNA bases at diffusion-controlled rates (k ~ 5–8 × 109 M−1 s−1 for guanine [57]); 
potentially generating other end products which can further propagate oxidative damage [58]. 
It is also worth highlighting exercise-induced peroxynitrite-derived radicals, namely carbonate 
and nitrogen dioxide radicals, could underlie some of the observed DNA damage [59]. 
Mechanistically, exercise could increase DNA damage by: (1) inhibiting repair; (2) increasing 
H2O2 production; and/or (3) increasing the labile redox-active transition metal pool. It follows 
that, one or more factors must simultaneously operate in the nucleus and mitochondria during 
exercise. The observed nuclear DNA damage likely requires H2O2 diffusion and/or generation 
proximally to the nuclear genome [55]. Although this likely occurs from other cellular organelles 
(such as the endoplasmic reticulum, or membrane-bound NADPH oxidases), the mitochondria 
may also contribute to nuclear DNA damage. Murphy (2012) outlines that mitochondrial H2O2 
has a large capacity for diffusion, and is hypothesised to play distinct roles in downstream 
physiological signalling responses, including post-translational modifications [61,62]. This 
retrograde signalling from the mitochondria to the nuclear domain may account for the 
potential of mitochondrial H2O2 to instigate nuclear DNA damage [55]. Given the topical 
interest around factor 2 combined with the ability of our findings reignite debate concerning 
the source of exercise induced superoxide, we wish to make three points: 
1. Mitochondrial superoxide production. Exercise is believed to reduce mitochondrial 
net O2·- production by increasing ATP demand. The continued availability of NADH 
means the flavin mononucleotide (FMN) group of complex I continues to produce 
superoxide at an appreciable rate in metabolic conditions mimicking exercise in 
isolated mitochondria. A potential source of the necessary H2O2, therefore, continues 
to operate. Moreover, the vast majority of redox research in an exercise setting 
recapitulates linear moderate/high intensity work and it could be argued the active 
recovery employed within this study creates a switch in ATP demand, potentially 
increasing mitochondrial O2·-/H2O2 production [63]; this highlights our limited 
understanding of exercising human in vivo mitochondrial redox dynamics. That is, 
cyclic fluxes in work done may induce oscillatory mitochondrial superoxide behaviour 
(i.e., troughs during the bout and peaks during the rest). Further, the persistent nature 
of mitochondrial superoxide production means a low rate of net production can cause 
damage over time.  
2. Mitochondrial antioxidant defence. In the absence of an overt increase in 
superoxide production, several factors could decrease mitochondrial antioxidant 
defence by limiting the activity of the NADPH dependent glutathione and thioredoxin 
systems. For example, ADP demand induce depolarisation may limit the activity of the 
proton motive force consuming transhydrogenase to decrease NADPH dependent 
defence.  
3. Cytosolic superoxide production. The present work details the mtDNA damage 
response in C2C12 myoblasts to H2O2 incubation at various concentrations from 50-
200 µM by sequestering the high concentrations of extramitochondrial H2O2 and 
recapitulating the exercise-induced Fenton reactions with transition metal ions; this 
dose-dependent response is indicative of other investigations using similar models 
[64–66]. The biological relevance of this is unclear and future work should include a 
propidium iodine exclusion assay to ascertain the mtDNA damage threshold by which 
H2O2 incubation induces cell death. In support, Goncalves et al. (2015, 2020) observed 
the greatest rate of H2O2 production occurs under resting conditions and becomes 
incrementally lower as exercise intensity increases as the redox centres that donate 
electrons to O2 become more oxidised. It could be hypothesised that as exercise 
intensity increases, H2O2 production from the electron transport chain decreases while 
simultaneously increasing the ability of the mitochondria to sequester 
extramitochondrial H2O2; thereby increasing the likelihood of Fenton-mediated 
reactions, and subsequent mtDNA damage. While the dose of H2O2 used is non-
physiological, it could be that H2O2 diffusing in increases mtDNA damage.  
 We show, for the first time, that MitoQ decreases exercise-induced DNA damage. We 
interpret the ability of MitoQ to decrease exercise induced DNA damage as beneficial. While 
we acknowledge oxidative damage adducts can signal, an increase in mtDNA damage is likely 
to be harmful. That said, it would be intriguing to determine whether an increase in mtDNA 
damage and the associated sensing is linked to mitochondrial biogenesis (i.e., repair could be 
coupled to an adaptive redox regulated response). If so, it is conceivable that MitoQ may be 
disadvantageous. Mechanistically, it is plausible that MitoQ offers protection to complexes I 
and IV (cytochrome c oxidase) of the electron transport chain from direct oxidative damage 
[68–71]. MitoQ may also indirectly affect superoxide production via reverse electron transfer 
by interacting with protonmotive forces (uptake decreases proton motive force) and the 
coenzyme Q pool redox state as detailed by Robb et al. (2018). It could also attenuate complex 
III mediated superoxide production by dissipating the proton motive force. Secondly, the 
prophylactic effects of MitoQ supplementation in PBMCs and skeletal muscle tissue observed 
could be attributable to direct scavenging of free radicals (RO· + MitoQH2 → ROH + MitoQ·-). 
If superoxide was protonated (as is postulated to occur at complex III; [73]), then MitoQ could 
intercept a diffusing species directly. Although kinetically feasible, it is improbable that MitoQ 
directly reacts with the hydroxyl radical as this would require MitoQ residing in close vicinity to 
mtDNA and outcompeting other hydroxyl radical targets. The more probable explanation is 
the attenuation of a peroxide-derived species as evident by Pham et al. (2020). Further, the 
mitochondria contain a high prevalence of lipids vulnerable to peroxidation (such as anionic 
cardiolipin, phosphatidylethanolamine, and phosphatidylcholine; [74]. Lipid peroxidation is 
generally initiated when a sufficiently reactive (i.e., thermodynamically and kinetically 
competent) free radical (hydroxyl radical) abstracts a bis-allylic hydrogen atom from a 
methylene group [75]; consequently, this process is propagated by unstable, adjacent lipid 
radicals (alkoxyl and peroxyl) [ROOH + Fe2+ → ROO. + Fe3+ + H+] [76,77]. This mechanism is 
consistent with others who demonstrate a positive correlation between lipid-derived alkoxyl 
free radicals, and oxidation of DNA and lipids following exercise [53,78]. Although alkoxyl free 
radicals were not measured in the present study, the increase in lipid peroxidation and DNA 
damage defines a plausible mechanism. Additionally, lipid-derived radicals formed within the 
mitochondrial bilayer could be released into a cytosolic environment [79]. It is highly likely that 
the reduction in mtDNA damage following chronic MitoQ supplementation was caused by the 
(indirect) attenuation of H2O2 concentration [34] and lipid-derived oxidants such as peroxyl 
and alkoxyl species. On a final note, MitoQ supplementation may also offer other prophylactic 
effects including the upregulation of antioxidant genes (HO-1, NQO-1, γ-GCLC, CAT, GPx; 
[34,70]), and exerting extramitochondrial prophylaxis as it cycles in and out of mitochondria in 
accordance with the membrane potential.  
 The inability of MitoQ to affect an acute change is likely attributable to insufficient 
uptake. There is a scarcity of human studies (especially in healthy, exercising populations) on 
the appropriate dosage to induce a prophylactic effect, thus, extrapolation of a human 
recommendation from animal studies is difficult. In addition, the lack of prophylaxis following 
acute supplementation may be explained by the oral consumption and first pass metabolism 
of the stomach and liver [80]. As a result, the rate and amount of MitoQ reaching systemic 
circulation within the hour absorption phase may be limited. Although bioavailability and 
tolerance of MitoQ has been clarified in vivo [22], an appropriate dose and delivery to the site 
of action have yet to be fully elucidated in human mitochondria. Consistent with increased 
bioavailability, chronic MitoQ supplementation provided a protective effect to nuclear and 
mtDNA in PBMCs and human muscle (mtDNA only) following HIIE.  
One intriguing insight uncovered was the lack of effect on the pre-exercise DNA 
damage following chronic MitoQ supplementation. Although this may appear trivial, it 
highlights our very limited understanding of exercise-mediated modifications to mitochondrial 
redox dynamics. For one, the majority of emerging evidence would suggest mitochondria 
generate the greatest amount of O2·-/H2O2 at rest [6,67,81], and as a result, it could be 
hypothesised that chronic MitoQ supplementation would have altered quiescent mitochondrial 
and/or nuclear DNA damage. It could potentially be the case that MitoQ does indeed alter 
State 4 mitochondrial O2·-/H2O2 dynamics which may not be detectable by measures of 
oxidative damage to DNA or lipids employed within the current study; especially considering 
the low levels of basal oxidative damage presented in healthy individuals [9,82,83]. This 
highlights the potential that MitoQ may be predominately applicable in conditions 
characterised by chronic oxidative stress and/or mitochondrial dysfunction such as chronic 
kidney disease, cardiovascular disease, acyl-CoA dehydrogenase deficiency, chronic 
obstructive pulmonary disorder, and neurodegenerative diseases [84–87].  
Interestingly, the present study failed to detect any effect of MitoQ supplementation on 
lipid peroxidation. Although the efficacy of general antioxidant supplementation and exercise-
induced oxidative stress has been well characterised [88–91], there is a scarcity of literature 
surrounding mitochondrial-targeted antioxidants in exercise. Despite different methods 
employed for the quantification of lipid peroxidation, neither Shill et al. (2016) nor the results 
of the present study demonstrated a prophylactic effect of chronic MitoQ supplementation. 
Mechanistically, there are several physiological variables which may explain these findings. 
The comparatively hydrophilic nature of MitoQ allows it to bind to the matrix-facing surface of 
the inner-mitochondrial membrane where it is continually recycled to the active antioxidant 
ubiquinol by complex II [92]. An additional point concerns the ability of coenzyme Q10 to 
recycle the α-tocopherol radical in the plasma membrane thereby attenuating ferroptosis by 
metabolising lipid radicals to hydroperoxides (ROO. [or RO.]+ α-TOH → ROOH [ROH] + α-
TOH·; CoQH2 + α-TOH· → α-TOH + CoQ·- radical) [93]; this mechanism could partially 
account for the lack of variation in lipid hydroperoxides and the reduction in mtDNA damage 
following chronic MitoQ supplementation. Conversely, our group has previously shown that 
lipid-derived radicals are released extracellularly [52,78,94]; as such, MitoQ may be unable to 
interact with these species, which may reconcile the lack of effect of supplementation on 
systemic lipid peroxidation. Further, the current study quantified lipid hydroperoxides within 
serum; thus, lacking the sensitivity and/or specificity to distinguish between mitochondrial and 
non-mitochondrial sources of lipid peroxidation. Future research should incorporate a several 
biomarkers (such as F2-Isoprostanes, 4-hydroxy-2-trans-nonenal etc.) across multiple tissue 
types to ascertain the extent, locality, and downstream consequences of targeted antioxidants 
on lipid peroxidation [95–97]. Moreover, it should be noted that nuclear DNA damage was 
detected using the comet assay which detects single-strand breaks and alkali-labile sites; 
however, greater sensitivity for the detection of more specific DNA lesions can be achieved 
by inclusion of endonuclease III, formamidopyrimidine DNA glycosylase, 8-oxoGua DNA 
glycosylase, and fluorescent in situ hybridisation, as previously applied [43,98,99]. 
 
5. Conclusions  
Our work demonstrates that HIIE damages mtDNA both systemically in lymphocytes and 
locally in muscle tissue, which occurs in parallel with nuclear DNA damage. While insufficient 
bioavailability likely explains the inability of acute MitoQ to impact DNA damage in 
mitochondria or the nucleus, chronic MitoQ supplementation safeguards both genomes 
against DNA damage in exercising humans. This study adds a number of key concepts to the 
exercise redox field: (1) HIIE induces mtDNA damage in lymphocytes and human muscle 
tissue likely through the generation of reactive oxygen and/or lipid-derived species; (2) Chronic 
MitoQ supplementation offers a prophylactic effect possibly by (i) directly or indirectly 
metabolising key reactive species, (ii) altering the activities of respiratory chain complexes, 
and/or (iii) exerting extramitochondrial effects; and (3) mitochondria may act as a sink to 
cytosolic H2O2. However, the relevance of this within exercising human muscle is unknown. 
This study offers novel, mechanistic insights to mitochondrial redox dynamics and targeted 
supplementation, and presents a number of exciting avenues for future research. From a wider 
perspective, that a protective effect of a mitochondria-targeted antioxidant was only unmasked 
by exercise reinforces the value of interrogating multiple physiological states when appraising 
the efficacy of an antioxidant.   
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Table 1. Utilised primers (forward and reverse) in human and C2C12 samples. All primers were previously 
































Table 2. Thermocycler variables associated with long- and short-mitochondrial primers. 
Phase Long Mito Primers Short Mito Primers 
Melting 94°C for 4 mins 94°C for 1 min 
Amplification 
26-28 cycles of melting 
(94°C for 15 secs) 
20 cycles of melting (94°C 
for 15 secs) 
Annealing 66°C for 12 mins 60°C for 45 sec 
Final Extension 72°C for 10 minutes 72°C for 45 sec 
Hold 
4°C (or 8°C if being held 
overnight) 









Table 3. Ascorbyl free radical concentration within serum following exercise in acute and chronic supplementation 
phases. † denotes a main effect of time (pooled pre- and post-exercise, P < 0.05). au = arbitrary units. 
 
Acute Chronic 
 Pre- Exercise Post-Exercise Pre- Exercise Post-Exercise 
MitoQ (au) 17038± 16733 27383± 14387† 18293± 15982 30283± 15892† 






Table 4. Serum lipid soluble antioxidant concentration following exercise in acute and chronic supplementation 
phases. All values are expressed as mmol·L-1. † denotes a main effect of time (pooled data; p < 0.05). 
 Acute Chronic 
 Pre-Ex Post-Ex Pre-Ex Post-Ex 
α-Tocopherol     
MitoQ 19.82 ± 0.9 22.97 ± 4.3
† 19.21 ± 0.6 25.69 ± 4.6† 
Placebo 18.13 ± 1.7 22.71 ± 3.5
† 17.62 ± 1.2 22.27 ±3.2† 
γ-Tocopherol     
MitoQ 1.53 ± 0.4 1.41 ± 0.3 1.63 ± 0.3 1.81 ± 0.4 
Placebo 1.72 ± 0.2 1.83 ± 0.7 1.81 ± 0.6 1.93 ± 0.8 
β-Carotene     
MitoQ 0.27 ± 0.08 0.29 ± 0.06 0.23 ± 0.07 0.24 ± 0.09 
Placebo 0.26 ± 0.07 0.24 ± 0.08 0.27 ± 0.07 0.24 ± 0.11 
Xanthophyll     
MitoQ 0.20 ± 0.09 0.25 ± 0.07 0.23 ± 0.11 0.26 ± 0.07 
Placebo 0.18 ± 0.11 0.21 ± 0.09 0.21 ± 0.12 0.25 ± 0.09 
Retinol     
MitoQ 1.83 ± 0.4 1.89 ± 0.6 1.69 ± 0.4 1.90 ± 0.8 
Placebo 1.76 ± 0.6 1.71 ± 0.9 1.88 ± 0.4 2.13 ± 0.6 
  
 
Figure 1. Schematic overview of experimental design. Participants remained in their assigned groups for the acute 








Figure 2. Heart rate (b·min-1) across high-intensity intermittent exercise. Note: HIIE 1 refers to exercise completed 
during the acute phase, whereas HIIE 2 refers to exercise completed during the chronic phase. Heart rate across 
both trials was similar (P > 0.05). 
 
Figure 3. Lymphocyte DNA damage following HIIE in (A) acute and (B) chronic MitoQ supplementation. Significant 
within group interaction effect (P < 0.05) was observed (not shown).* denotes a significant interaction effect (P < 




Figure 4. Lymphocyte mitochondrial DNA damage following HIIE in (A) acute and (B) chronic MitoQ 
supplementation. Note: # indicates a main effect of time (P < 0.05). * represents a significant interaction effect of 






Figure 5. Muscle mitochondrial DNA damage following HIIE and chronic MitoQ supplementation. Note: # indicates 






Figure 6. Hydrogen peroxide series on C2C12 mouse muscle cells; acting as positive control for LA-qPCR utilised 








Figure 7. (A) Lipid hydroperoxides following HIIE across the acute phase. (B) Lipid hydroperoxides following HIIE 
across the chronic phase. * represents a significant within group effect (P < 0.05). 
 
 
 
 
 
